Abbonarsi

Data feedback and clinical process improvement in acute myocardial infarction - 21/08/11

Doi : 10.1016/j.ahj.2004.05.057 
Huiling Zhang, MD, MPH a, , Julia A. Alexander, MS a, Josiah Luttrell, MS a, Gerald T. O'Connor, PhD, DSc b, c, Jennifer Daley, MD a, Martin Paris, MD, MPH a
a Clinical Quality Department, Tenet Healthcare Corporation, Dallas, Tex 
b Department of Medicine, Center for Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH 
c Department of Community and Family Medicine, Center for Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH 

*Reprint requests: Huiling Zhang, MD, MPH, Clinical Quality Department, Tenet Healthcare Corporation, 13737 Noel Road, Suite 100, Dallas, TX 75240.

Riassunto

Background

Numerous reports have shown substantial undertreatment of acute myocardial infarction (AMI). The goal of this intervention study was to improve both the acute and discharge care of patients with AMI. Thirty-eight Tenet hospitals participated in a cardiac improvement collaborative called the Partnership for Change. Interventions included the implementation of a computerized concurrent data feedback system and the organization, staffing, and deployment of performance improvement teams at each hospital.

Methods

Data were collected on 11394 patients with AMI between January 1, 2001, and June 30, 2002. We calculated rates of treatments including aspirin (first 24 hours and at discharge), β-blocking agent (first 24 hours and at discharge), reperfusion using thrombolysis (first 30 minutes) or percutaneous intervention (first 2 hours), angiotensin-converting enzyme inhibitor (at discharge), smoking cessation counseling (during hospital stay), and referral to a cardiac rehabilitation program (at discharge).

Results

Statistically significant increases were seen for all indicators. Aspirin use during the first 24 hours increased from 86.4% to 96.5% and use at discharge increased from 70.0% to 87.4%. The use of β-blocking agents during the first 24 hours increased from 51.4% to 88.4% and use at discharge increased from 62.4% to 83.5%. Reperfusion during the first 2 hours increased from 25.9% to 35.3%. Discharge use of angiotensin-converting enzyme inhibitors increased from 29.3% to 43.3%. Smoking cessation counseling increased from 35.1% to 80.6%. Referral to a cardiac rehabilitation program increased from 16.9% to 41.7%. All P values were <.001.

Conclusions

The implementation of a rapid-cycle computerized concurrent data feedback system along with on-site process improvement teams was associated with a substantial increase in the use of both acute and discharge treatments for AMI.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2005  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 149 - N° 5

P. 856-861 - maggio 2005 Ritorno al numero
Articolo precedente Articolo precedente
  • Depression and heart failure in patients with a new myocardial infarction
  • Lynda H. Powell, Diane Catellier, Kenneth E. Freedland, Matthew M. Burg, Susan L. Woods, Vera Bittner, James E. Calvin, James A. Blumenthal, for the ENRICHD Investigators
| Articolo seguente Articolo seguente
  • Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: Results of a randomized trial
  • Robert D. Reid, William A. Dafoe, Louise Morrin, Alain Mayhew, Sophia Papadakis, Louise Beaton, Neil B. Oldridge, Douglas Coyle, George A. Wells

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.